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Introduction
Scleritis is a severe inflammatory disease characterized by
edema and inflammatory cell infiltration of the sclera [1, 2].
Without treatment, the condition may be progressively
destructive, leading sometimes to loss of vision or loss of
the eye [1, 2].
About 30–50% of all scleritis patients have an associated
systemic disease [1]. Most common associations are:
rheumatoid arthritis (50–60%) and primary systemic vas-
culitis like Wegener’s granulomatosis (20%) followed by
inflammatory bowel disease (15%) [1].
Complications have been reported in almost 60% of
scleritis patients [1, 2]. In their series, Jabs et al. found
decreased visual acuity in 15.9% of patients during the
inactive phase of the disease [1]. Sainz de la Maza et al.
described this complication in 37% of their patients [2].
Some authors have reported transient myopia during the
acute phase of anterior diffuse [3] and necrotizing scleritis
[4]. In one report transient myopia developed after cataract
surgery in a patient with necrotizing scleritis [5]. Secondary
astigmatism in patients with necrotizing scleritis has also
been found. The authors associated this finding to scleral
thinning [6].
To the best of our knowledge, no attempt to systemat-
ically characterize the refractive changes associated to
scleritis has been done. Our purpose was to determine the
clinical characteristic, scleral rigidity, and refractive
changes in a cohort of scleritis patients who were followed
up since admittance until resolution of inflammation.
Material and methods
This protocol was reviewed and approval by the hospital
ethics committee and has been performed in accordance
with the ethical standards laid down in the 1964 Declara-
tion of Helsinki. All the patients gave their informed
consent prior to their inclusion in the study.
We included patients of the Inflammatory Eye Diseases
Clinic of the “Dr. Luis Sánchez Bulnes” Hospital, with a
diagnosis of noninfectious active anterior scleritis with or
without associated systemic disease. Immunosuppressive
treatment was prescribed according to the associated
disease. All patients signed an informed consent form to
be included in the study. Demographic data of patients were
obtained. Type and location of scleral inflammation and
associated systemic disease were also recorded. Best
corrected visual acuity (BCVA), spherical and cylindrical
error, intraocular pressure (IOP), and scleral rigidity were
measured. Initially, an auto-refraction was made (Topcon
RM-A2300) followed by a mono-ocular subjective refrac-
tion with Snellen chart, spherical power was determining by
the red–green test, and the cylinder by the cross cylinder
technique. Because all the patients were adult, cycloplegic
refraction was not realized. The scleral rigidity coefficient
was determinate according to Friedenwald’s nomogram
using a Schiotz tonometer [7]. Briefly, after 15 min on
supine decubitus and previous application of topical
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with 5.5 and 7.5 weights; there is a modification of the
technique, where these two measures are compared with the
IOP taken with Goldman tonometer; finally, in the
Friedenwald’s nomogram, we searched the point where
both IOP measurements intersect. All measurements were
done by the same ophthalmologist (MCPD) [7, 8].
Patients were evaluated during the active and inactive
phases of disease. Minimum follow-up time was 6 months.
Central tendency statistical of data were obtained. Wilcoxon
ranked signed test was performed to compare initial and final
data of BCVA, IOP, refractive error, and coefficient of scleral
rigidity. Statistically significant p value was <0.05.
Results
Four female patients (seven eyes) were included. Average age
at admission was 54 years (±3 SD). Mean follow-up time was
20months(±4SD).Wegener’sgranulomatosiswasdiagnosed
in two patients, rheumatoid arthritis in one, and the fourth had
a positive serology for the HLA-B27 antigen. Diffuse scleritis
was found in one eye and nodular scleritis in six eyes. Most
common nodule location was superior (three eyes): Inferior,
nasal, and temporal locations were found in one eye each.
When we compared values during the active and inactive
inflammation (Table 1), we found that in four eyes the
cylindrical power increased at least 1D, and that the axis
changed at least 10°. In one eye there was a myopic shift of
1D. All patients had a scleral rigidity coefficient lower than
the value reported as normal by Friedenwald (0.0215). This
reduction was found in both the active (0.0197) and
inactive phases (0.0118). A statistically significant differ-
ence in cylindrical axis and scleral rigidity coefficient was
found when we compared them during active and inactive
inflammation stages. These results must be taken with
precaution due to the small number of patients.
Discussion
We are unaware of previous reports evaluating refractive
changes in patients with scleritis. Jabs et al. reported an
associated systemic disease in 27% of their group of
patients. The authors did not find any statistically signifi-
cant association between final visual acuity and the
presence of corneal alterations, cataracts, posterior segment
complications, or intraocular inflammation. The refractive
status of those patients was not evaluated [1].
Some considerations must be taken into account when
analyzing the results, the most important is the small
number of patient studied, also the lack of corneal
topographic changes measured.
Comparing the initial (active inflammation) and final
(inactive inflammation) values in our group of patients, we
found in four eyes an increase of at least 1D in the
cylindrical power, in these cases, the cylindrical axis
changed at least 10°. In one eye a 1D myopic shift was
found.
In all the studied eyes, there was a 10–15% decrease in
the scleral rigidity coefficient in the final measurement, in
all cases this value was lower than the normal value
reported by Friedenwald [7].
A statistically significant difference in cylindrical axis
and scleral rigidity coefficient was found during the active
and inactive inflammation phases. Our findings suggest that
the modification of the scleral rigidity induces an alteration
in the stability of the corneal contour at the limbus. This
scleral–corneal interaction was reported by Newton and
Meek in 1998 [9]. They described that at the limbus, the
deep fibers of the sclera tighten to form the scleral spur, a
rigid ring structure that together with the corneal annulus
(which is formed by a circumferential swath of limbal
fibrils originating in the cornea) probably accounts for the
stability of the corneal contour.
Inflammation of the sclera seems to alter the scleral
structure. Fibroblastic transformation, breakdown of pro-
teoglycan linkages, and degeneration of collagen fibrils
have been found in the inflamed sclera [10], these
alterations may permanently modify the scleral structure
and rigidity. If this change affects the scleral spur and
consequently the corneal annulus, an alteration of the
stability of the corneal contour may be expected, explaining
the modification in the cylinder axis, observed in our cases.
We have hypothesized that the initial (active phase)
increased thickness and scleral edema (5) producing a force
Variable Active phase, mean (range) Inactive phase, mean (range) P value
Visual acuity 20/30 (20/50–20/20) 20/30 (20/50–20/20) 0.83
Intraocular pressure (mmHg) 11.71 (10–16) 13.0 (12–15) 0.60
Sphere (D) −0.50 (+4.00 to −4.75) +1.75 (+5.00 to −3.75) 0.17
Cylinder (D) −4.07 (−0.75 to −6.00) −4.10 (−0.75 to −6.00) 0.08
Axis cylinder (degrees) 110.8 (9–174) 59 (4–170) 0.02
Scleral rigidity
a 0.0197 (0.0177–0.0244) 0.0118 (0.0053–0.0183) 0.02
Table 1 Clinical, refractive and
scleral rigidity characteristics
aAverage scleral rigidity coeffi-
cient according to Friedenwald’s
nomogram
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the inactive phase, the decrease of the strength of the limb
associated with the loss of scleral tissue (5) and the
secondary loss of structural support in the necrotic area of
the limbus could work like a belt that exerts its force
centripetally, allowing the central dome of the cornea to be
displaced anteriorly, thus increasing its curvature.
Conclusions
In this small group of patients with autoimmune anterior
scleritis, we observed a modification of the scleral rigidity
coefficient values and refractive changes during the course of
the disease. These alterations may explain some cases of
decreased VA, in patients with inactive scleral inflammation
that is not explained by corneal abnormalities, cataracts,
posterior segment complications,or intraocular inflammation.
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